X
20
Debiopharm International S.a. Lausanne Ch, based in Switzerland, is a pharmaceutical company.
One of their significant offerings is Oxaliplatin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-229 - Rev 05
This Chemical Type CEP, issued on October 18, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2017 associated with this CEP further emphasizes